Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
08/2002
08/22/2002US20020115867 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
08/22/2002US20020115860 Compositions and methods for hydration of terminal alkynes
08/22/2002US20020115724 Methods and agents for inhibiting protein aging
08/22/2002US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
08/22/2002US20020115703 Administering an alpha2-adrenoceptor antagonist or a pharmaceutically acceptable ester or salt thereof, such as atipamezole, analogs of idazoxan, and analogs of efaroxan.
08/22/2002US20020115702 Administering substituted imidazoles, particular by losartan potassium, treatment of post-transplant hypertension.
08/22/2002US20020115693 Treating a variety of central and peripheral disorders; useful as positive controls in assays for BK-2 receptor activity and when appropriately labeled as probes for the localization of BK-2 receptors in tissue sections.
08/22/2002US20020115685 Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/22/2002US20020115653 Retinoic acid mimetic anilides
08/22/2002US20020115640 Such as 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl) methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile; anticancer agents
08/22/2002US20020114770 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits
08/22/2002DE10114425C1 Diaminobenzol-Derivate und diese Verbindungen enthaltende Haarfärbemittel Diaminobenzene derivatives and compositions containing these compounds hair dye
08/22/2002DE10106642A1 Verfahren zur Herstellung von (Meth)acrylsäureestern durch Umesterung in Gegenwart von Alkalimetallcyanat enthaltenden Mischkatalysatoren A process for preparing (meth) acrylic acid esters by transesterification in the presence of mixed catalysts containing alkali metal cyanate
08/22/2002CA2438105A1 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione
08/22/2002CA2437809A1 Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence
08/22/2002CA2437760A1 Selective substituted aryl ketone and safener based herbicides
08/21/2002EP1233015A1 Use of imidazole derivatives for the treatement of deseases involving the AT1 and AT2s receptors of angiotensine, some of these products, their preparation, their application as medicaments and pharmaceutical compositions containing them
08/21/2002EP1232164A1 Pre-cursor for radiodiagnostic agents and the production thereof
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002EP1231939A2 Oncolytic combinations for the treatment of cancer
08/21/2002EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
08/21/2002EP0802179B1 Substituted amidinonaphthyl ester derivatives
08/21/2002EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
08/21/2002CN1089251C Vapor sterilization using a non-aqueous source of hydrogen peroxide
08/20/2002US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors
08/20/2002US6437149 Cationic aminoanthraquinones, their use for dyeing keratinous fibers, dyeing compositions containing them and methods of dyeing
08/20/2002US6437148 Intermediates for (R)-3(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one
08/20/2002US6437133 Method of catalytically removing a protective group containing an allyl group using a reducing agent
08/20/2002US6437129 Armoatic or heteroarmoatic compound containing substituted amides or thioamides
08/20/2002US6437121 Cationic lipids
08/20/2002US6436999 Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
08/20/2002US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
08/20/2002US6436962 Alpha 1a adrenergic receptor antagonists; relief from benign prostatic hyperplasia by less hindered urine flow by relaxing smooth muscle tissue; with a testosterone 5-alpha reductase inhibitor, finasteride; acute and chronic relief
08/20/2002US6436928 Selective neurokinin antagonists
08/20/2002US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/15/2002WO2002062766A2 Melanocortin-4 receptor binding compounds and methods of use thereof
08/15/2002WO2002062762A2 Potassium channel openers
08/15/2002WO2002062750A1 Cannabinoid receptor ligands
08/15/2002WO2002062324A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
08/15/2002WO2002062301A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/15/2002WO2002042244A3 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
08/15/2002WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses
08/15/2002WO2001096307A3 Cycloalkyl alkanoic acids as integrin receptor antagonists
08/15/2002WO2001072685B1 Polyamine analogues as cytotoxic agents
08/15/2002US20020111512 Dynamic resolution of isomers and resolved isomers
08/15/2002US20020111511 Process for synthesis of (meth) acrylic acid esters by transesterification in the presence of mixed catalysts containing alkali metal cyanate or thiocyanate
08/15/2002US20020111497 Reacting azolide salts with phosgene in an aromatic compound or an ether as solvent
08/15/2002US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors
08/15/2002US20020111345 Use of taurolidine to treat tumors
08/15/2002US20020111338 Bile-acid conjugates for providing sustained systemic concentrations of drugs
08/15/2002US20020108187 3-(2-(quaternary ammonium)ethylamino)phenol halides such as 1-(2-(3-hydroxy-4-methyl-phenylamino)-ethyl)-3-methyl 3H-imidazol-1-ium chloride; orange couplers
08/15/2002CA2437405A1 Potassium channel openers
08/15/2002CA2437380A1 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
08/15/2002CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/14/2002EP1231210A2 Azole antifungal agents, processes for the preparation thereof, and intermediates
08/14/2002EP1231208A2 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
08/14/2002EP1231202A2 Transesterification of (meth)acrylates in presence of alkali metal cyanate containing mixed catalysts
08/14/2002EP1230249A1 Transition metal complexes with bidentate ligand having an imidazole ring
08/14/2002EP1230248A2 Transition metal complexes attached to a polymer via a flexible chain
08/14/2002EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
08/14/2002EP0937076B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
08/14/2002EP0754683B1 Ether compound, use thereof, and intermediate for producing the compound
08/14/2002EP0722439B1 Hiv protease inhibitors
08/14/2002DE10106420A1 Selektive Herbizide auf Basis von substituierten Arylketonen und Safenern Selective herbicides based on substituted aryl ketones and safeners
08/14/2002DE10106214A1 Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz New alkyl-phenylimino-imidazolidine derivatives for treating urinary incontinence
08/14/2002CN1364167A Endogenous constitutively activated G protein-coupled orphan receptors
08/14/2002CN1364158A Mutilin derivatives and their use as antibacterials
08/14/2002CN1364156A Novel naphthalene ureas as glucose uptake enhancers
08/14/2002CN1364155A N-Cyanomethyl amides as protease inhibitors
08/13/2002US6433185 N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/13/2002US6433183 (R)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-3-methyl-1,6-dihydroimidazo[1,2-a]imidazole-2,5-dione
08/13/2002US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
08/13/2002US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents
08/13/2002US6433002 Pesticidal 1-polyarylpyrroles
08/13/2002US6432947 N-heterocyclic derivatives as NOS inhibitors
08/08/2002WO2002060907A1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
08/08/2002WO2002060881A1 Process for the synthesis and recovery of nitramines
08/08/2002WO2002060877A1 Imidazole derivatives
08/08/2002WO2002060874A1 Potassium channel inhibitors
08/08/2002WO2002018327A3 Guanidinobenzamides as mc4-r agonists
08/08/2002WO2002010140A3 Imidazolyl derivatives
08/08/2002WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
08/08/2002WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
08/08/2002US20020107411 Such as 25-hydroxy-3-aminopropoxyvitamin D3 biotinamide; kits
08/08/2002US20020107290 Inhibiting activated blood-coagulation factor X
08/08/2002US20020107272 Anti-HIV imidazolone derivatives
08/08/2002US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
08/08/2002CA2432783A1 Potassium channel inhibitors
08/07/2002EP1229023A1 Thioimidazolidine derivatives as oil-soluble additives for lubricating oils
08/07/2002EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
08/07/2002EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
08/07/2002EP1228053A1 Substituted piperazine derivatives, the production and use thereof as inhibitors of the microsomal triglyceride transfer protein (mtp)
08/07/2002EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
08/07/2002EP1227811A2 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions
08/07/2002EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
08/07/2002EP1058679A4 Synthesis of epothilones, intermediates thereto and analogues therof
08/07/2002CN1362951A Dihetero-substituted metalloprotease inhibitors
08/07/2002CN1362947A N-cyanomethylamides as protease inhibitors
08/07/2002CN1088709C Amine compound and its acid addition salt
08/06/2002US6429328 Processes and intermediate compounds for preparing guanidine and amidine derivatives